AGP Executive Report
Last update: 5 hours agoADHD & Growth: A large South Korea study following kids with ADHD into adulthood found they had higher adult BMI and obesity odds, raising questions about long-term effects of methylphenidate. Cancer Care Trials: A randomized trial reports neoadjuvant apalutamide may help preserve potency in high-risk localized prostate cancer, while Stony Brook Medicine is testing a HER2 tumor vaccine to cut recurrence risk. Diabetes Kidney Risk: Bio Preventive Medicine and Precision Diabetes tout DNlite™ as a new way to flag renal risk in type 2 diabetes and CKD beyond standard markers, using CREDENCE trial data. Med Safety & Access: Experts urge banning Kambo “frog detox” after reported deaths; meanwhile, a Cebu City proposal would let people check pharmacy medicine availability in real time. Medicaid Pressure in the US: A survey finds most Medicaid enrollees don’t know 2027 work requirements are coming, and Minnesota disenrolled 3,411 providers, leaving many scrambling for care. Public Health Alerts: Lake Nokomis beaches face E. coli and blue-green algae advisories. Global Outbreak Watch: Ebola cases are surging in DRC as testing accelerates. Policy & Records: RFK Jr. seeks access to Americans’ identifiable medical records, fueling privacy and legal concerns. Traditional Medicine: China and Pakistan expand herbal medicine cooperation with a joint laboratory. Healthcare Leadership: Penn Medicine extended CEO Kevin Mahoney’s contract through June 2031.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.